Navigation Links
Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
Date:2/14/2008

PARIS, February 14 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the Chicago Athenaeum Museum of Architecture and Design has awarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposable insulin injection pen for people with type 1 and type 2 diabetes.

"LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the results of over four years of intensive development, have been designed in dialogue with patients, nurses and doctors and meet the high standards of the industry," said Paul Jansen, Global Head Medical Devices, sanofi-aventis.

"We are proud to receive this prestigious GOOD DESIGN Award for SoloSTAR(R) as a recognition of our strong commitment to people with diabetes", Gilles Lhernould, Senior Vice President Industrial Affairs sanofi-aventis added.

For some people with diabetes, self-injection can be a barrier to acceptance of insulin therapy. "SoloSTAR(R) is a marriage of sleek, handsome design styling with easy, but advanced sophisticated technology for dispensing insulin to people with diabetes," says Christian K. Narkiewicz-Laine, President Chicago Athenaeum Museum of Architecture and Design. "SoloSTAR(R) represents a design for social good and for humanitarian concerns".

When choosing a specific insulin pen for an individual patient, clinicians consider the patient's insulin regimen, lifestyle, and other factors that may affect the ability to use a particular device, such as manual dexterity and visual acuity. Therefore certain characteristics of a given insulin pen may make it preferable for patients. The outstanding design of SoloSTAR(R) using breakthrough technology contributes to making this patients' and clinicians' choice easier.

SoloSTAR(R) provides a delivery option that may be more acceptable and more convenient to use in comparison with other delivery systems, thus may promote patient compliance, which could help achieve and maintain glycemic control.

A recent survey of LANTUS(
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. Smart insulin nanostructures pass feasibility test, UT study reports
5. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
6. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
7. Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
8. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
9. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
10. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... and NYSE: SNY) today announced that the Companies intend ... rare pediatric disease priority review voucher in connection with ... priority review voucher entitles the holder to designate a ... 6-month review from the filing date instead of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears are ... Academy of Dermatology (Academy) in an effort to raise ... Bears will host free SPOT me™ skin cancer screenings ... at Soldier Field. SPOT me™ is an educational ... the dangers and risks of skin cancer, and encourages ...
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
(Date:7/30/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... in Industrial Applications , the global market for industrial ... by 2018, registering a five-year compound annual growth rate ... recorded in the detergent enzyme segment with a CAGR ... has influenced almost every sector of industrial activity, ranging ...
Breaking Biology Technology:Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3
... (NYSE: SGP ) announced that Nippon Organon ... Drug Application with the Japanese,Ministry of Health, Labour ... selective relaxant binding agent (SRBA), sugammadex., Sugammadex ... the effects of certain muscle relaxants, rocuronium bromide,(marketed ...
... The Science and Technology Foundation of,Japan announced the ... Japan,Prize today., All three laureates this year ... and Dr. Robert Elliot Kahn who received their ... for the,Internet" in the prize category of "Information ...
... Both Clinical Trial Experience and Business ... CAMBRIDGE, Mass., Jan. 16 Cytel, Inc. ... Irving Dark has,accepted the role of Vice President ... Cytel 15-years of management experience guiding drug,biologic and ...
Cached Biology Technology:Schering-Plough Announces Sugammadex New Drug Application Filed in Japan 2Schering-Plough Announces Sugammadex New Drug Application Filed in Japan 3American Scientists Named as Laureates of the 2008 (24th) Japan Prize 2Irving Dark Named Vice President of Cytel Clinical Research Services 2
(Date:7/30/2014)... in female baboons suggests that the route to a higher ... have lots of supportive sisters. , A female baboon,s social ... the rank of her mother - the higher the mother ... reason, dominance rank in female baboons is thought to be ... a good spot in the pecking order, whereas females born ...
(Date:7/30/2014)... could be as simple as inserting a medicated, disappearing ... Washington bioengineers have discovered a potentially faster way to ... HIV. Their method spins the drug into silk-like fibers ... higher doses of the drug than possible with other ... could offer women a potentially more effective, discreet way ...
(Date:7/30/2014)... ranges and a changing climate threaten some of ... and so conservationists establish seed collections to save ... hopes of preserving some genetic diversity., For decades, ... models that offer a one-size-fits-all approach for how ... 50 seed samples regardless of species, pollination mode, ...
Breaking Biology News(10 mins):Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3Saving seeds the right way can save the world's plants 2
... global carbon cycle, helping sequester significant amounts of carbon. ... that they discolor coastal waters and reduce the amount ... known as "red tide," the term "harmful algal blooms" ... of algal biomass can sometimes also turn the ocean ...
... of scientists studying genetic pathways that are mutated in ... forms of congenital heart disease including hypertrophic cardiomyopathy ... the leading cause of sudden death in children and ... and successfully treated HCM in the lab. ...
... Massachusetts Institute of Technology biologist Graham Walker leads a ... recreate the creativity and excitement of his research lab: ... MIT colleagues to identify new research questions in science ... Walker will talk about his experiences running a science ...
Cached Biology News:Brown tide culprit sequenced: Genome of the first of algal bloom species 2Brown tide culprit sequenced: Genome of the first of algal bloom species 3Brown tide culprit sequenced: Genome of the first of algal bloom species 4Cancer-related pathways reveal potential treatment target for congenital heart disease 2Cancer-related pathways reveal potential treatment target for congenital heart disease 3Plenary speech by HHMI professor highlights efforts of scientist-educators 2Plenary speech by HHMI professor highlights efforts of scientist-educators 3
... Translation System is ideal for both radioactive ... Translation System: Provides five pre-mixed nucleotide ... Yields >10 8 cpm/g control ... to monitor the performance of the system ...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
... Direct SPA Screening Assay, 5 ... that eliminate lengthy sample extraction procedures ... use).Range: 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ... 2-8 C. Category: Drug Screening & ...
Biology Products: